At a Glance
7thirty Capital is a New York-based venture capital firm founded in 2017 that specializes in cannabis technology investments across medical technology, agricultural technology, and software-as-a-service sectors. The firm positions itself at the intersection of the rapidly evolving cannabis industry and transformative technology solutions.
The firm's investment approach focuses on identifying companies that leverage technology to address key challenges within the cannabis ecosystem, from cultivation and processing to compliance and distribution. 7thirty Capital typically invests in seed and Series A stage companies, targeting entrepreneurs who are building scalable solutions for the cannabis market's unique regulatory and operational requirements.
What distinguishes 7thirty Capital is its specialized focus on cannabis technology at a time when many traditional VCs have been hesitant to enter the space due to regulatory complexities. The firm's deep understanding of cannabis industry dynamics, combined with its technology investment expertise, allows it to identify opportunities that bridge the gap between emerging cannabis markets and proven technology solutions.
“Cannabis-technology specialist in med-tech, ag-tech, and SaaS.”
7thirty Capital primarily invests at the Seed, Series A stages. This means they focus on companies that are building their initial product and finding product-market fit.
7thirty Capital is headquartered in New York, NY. Many of their portfolio companies are also based in this region, though they invest across geographies.
7thirty Capital focuses on investments in Agriculture, SaaS, Other. Their portfolio reflects deep expertise and networks within these sectors.
7thirty Capital's typical investment check size ranges from $100K to $1M. Actual amounts may vary based on the stage, sector, and specific opportunity.
